- Home
- MAMK vs STTK Comparison
MAMK vs STTK Comparison
Compare MAMK & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMK
- STTK
- Stock Information
- Founded
- MAMK 2007
- STTK 2016
- Country
- MAMK China
- STTK United States
- Employees
- MAMK N/A
- STTK N/A
- Industry
- MAMK Apparel
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- MAMK Consumer Discretionary
- STTK Health Care
- Exchange
- MAMK Nasdaq
- STTK Nasdaq
- Market Cap
- MAMK 43.2M
- STTK 49.3M
- IPO Year
- MAMK 2025
- STTK 2020
- Fundamental
- Price
- MAMK $2.16
- STTK $0.98
- Analyst Decision
- MAMK
- STTK Hold
- Analyst Count
- MAMK 0
- STTK 5
- Target Price
- MAMK N/A
- STTK $2.00
- AVG Volume (30 Days)
- MAMK 92.8K
- STTK 5.4M
- Earning Date
- MAMK 01-01-0001
- STTK 08-14-2025
- Dividend Yield
- MAMK N/A
- STTK N/A
- EPS Growth
- MAMK N/A
- STTK N/A
- EPS
- MAMK 0.12
- STTK N/A
- Revenue
- MAMK $21,434,100.00
- STTK $2,997,000.00
- Revenue This Year
- MAMK N/A
- STTK N/A
- Revenue Next Year
- MAMK N/A
- STTK N/A
- P/E Ratio
- MAMK $17.87
- STTK N/A
- Revenue Growth
- MAMK N/A
- STTK N/A
- 52 Week Low
- MAMK $1.87
- STTK $0.69
- 52 Week High
- MAMK $4.00
- STTK $3.95
- Technical
- Relative Strength Index (RSI)
- MAMK N/A
- STTK 55.91
- Support Level
- MAMK N/A
- STTK $0.79
- Resistance Level
- MAMK N/A
- STTK $1.05
- Average True Range (ATR)
- MAMK 0.00
- STTK 0.09
- MACD
- MAMK 0.00
- STTK 0.01
- Stochastic Oscillator
- MAMK 0.00
- STTK 75.14
About MAMK MaxsMaking Inc. Class A Ordinary Shares
MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.